Polycystic Ovary Syndrome
"Polycystic Ovary Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.
| Descriptor ID |
D011085
|
| MeSH Number(s) |
C04.182.612.765 C13.351.500.056.630.580.765 C19.391.630.580.765
|
| Concept/Terms |
Polycystic Ovary Syndrome- Polycystic Ovary Syndrome
- Ovary Syndrome, Polycystic
- Syndrome, Polycystic Ovary
- Stein-Leventhal Syndrome
- Stein Leventhal Syndrome
- Syndrome, Stein-Leventhal
- Sclerocystic Ovarian Degeneration
- Ovarian Degeneration, Sclerocystic
- Sclerocystic Ovary Syndrome
- Polycystic Ovarian Syndrome
- Ovarian Syndrome, Polycystic
- Polycystic Ovary Syndrome 1
|
Below are MeSH descriptors whose meaning is more general than "Polycystic Ovary Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Polycystic Ovary Syndrome".
This graph shows the total number of publications written about "Polycystic Ovary Syndrome" by people in this website by year, and whether "Polycystic Ovary Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2005 | 2 | 0 | 2 |
| 2006 | 2 | 0 | 2 |
| 2009 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 21 | 3 | 24 |
| 2018 | 21 | 2 | 23 |
| 2019 | 14 | 1 | 15 |
| 2020 | 2 | 0 | 2 |
| 2021 | 5 | 0 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Polycystic Ovary Syndrome" by people in Profiles.
-
Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study. Eur J Endocrinol. 2021 May; 184(5):637-645.
-
SARS-CoV-2 Viral Entry Proteins in Hyperandrogenemic Female Mice: Implications for Women with PCOS and COVID-19. Int J Mol Sci. 2021 Apr 25; 22(9).
-
Comment on "Androgens and women: COVID-19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism". Int J Dermatol. 2021 Sep; 60(9):e337-e338.
-
Androgens and women: COVID-19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism. Int J Dermatol. 2021 Jul; 60(7):e267-e268.
-
Sex, Hormones, Immune Functions, and Susceptibility to Coronavirus Disease 2019 (COVID-19)-Related Morbidity. Obstet Gynecol. 2021 03 01; 137(3):423-429.
-
Vitamin D Association With Macrophage-Derived Cytokines in Polycystic Ovary Syndrome: An Enhanced Risk of COVID-19 Infection? Front Endocrinol (Lausanne). 2021; 12:638621.
-
Metformin turns 62 in pharmacotherapy: Emergence of non-glycaemic effects and potential novel therapeutic applications. Eur J Pharmacol. 2021 May 05; 898:173934.
-
Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome. J Transl Med. 2021 02 11; 19(1):63.
-
Androgens, the kidney, and COVID-19: an opportunity for translational research. Am J Physiol Renal Physiol. 2021 02 01; 320(2):F243-F248.
-
Coronavirus Disease 2019 (SARS-CoV-2) and polycystic ovarian disease: Is there a higher risk for these women? J Steroid Biochem Mol Biol. 2021 01; 205:105770.